THE BUSINESS OF LONGEVITY – Chapter Six

Behind the Foundation

Following the Corporate Structure

When investigating any organisation, one question inevitably follows another.

Who owns it?

Who controls it?

Where is it incorporated?

Which company owns the intellectual property?

Which company receives patient revenue?

Which company raises investment?

Which company employs the staff?

These are ordinary questions.

They are asked every day by banks, institutional investors, regulators and corporate lawyers conducting due diligence.

Yet for members of the public, they are often surprisingly difficult to answer.

As my investigation into Wellbeing International Foundation progressed, I found myself asking exactly the same questions.

The answers were not immediately obvious.

Looking Beyond the Website

A company's website tells you what it wants you to know.

Corporate records tell you how the organisation is actually built.

Those are two very different things.

Most people searching for Wellbeing International Foundation will find information about regenerative medicine, longevity research and Cell-Free Therapy.

Dig a little deeper, however, and a much more complicated picture begins to emerge.

Instead of a single organisation, there appears to be a network of companies, jurisdictions, research activities and commercial operations.

Understanding how those pieces fit together is essential.

Not because complexity is unusual.

But because transparency matters.

The Meaning of "Foundation"

The word Foundation carries weight.

To many people it suggests research, education, philanthropy or charitable activity.

It creates an impression of public purpose.

There is nothing preventing a commercial organisation from using the word "Foundation" as part of its name.

Equally, the name itself does not explain the legal structure behind the organisation.

As I reviewed Wellbeing's public material, I found references to:

• patient revenue;

• private investment;

• research programmes;

• commercial expansion;

• international clinical partnerships;

• intellectual property development.

Those activities are entirely capable of existing within one organisation.

They also raise a perfectly reasonable question.

What exactly is the legal structure supporting all of this activity?

Bermuda

Wellbeing states that it is headquartered in Bermuda.

Bermuda has long been recognised as an international financial centre.

Many perfectly legitimate multinational businesses choose to incorporate there for commercial, legal or tax reasons.

The jurisdiction itself is not the story.

The story is transparency.

Unlike publicly listed companies in many jurisdictions, privately held companies incorporated in Bermuda may have relatively limited financial information available to the public.

That does not imply secrecy.

Nor does it imply wrongdoing.

It simply means that journalists, patients and prospective investors have fewer independent documents available when attempting to understand a company's financial position.

As a result, much greater reliance is placed upon company statements.

Following the Money

One of the most interesting discoveries during this investigation was Wellbeing's announcement that it had successfully completed the first tranche of its 2026 investment round.

The announcement confirmed that capital had been raised.

It also confirmed that details of the investment remained private.

The company did not publicly disclose:

• the amount raised;

• the valuation of the business;

• the identities of investors;

• the type of investment instrument used;

• shareholder dilution;

• ownership percentages.

For a privately held company, there is nothing inherently unusual about maintaining confidentiality.

However, for anyone attempting to conduct independent due diligence, those omissions create obvious limitations.

Understanding how a business is financed is often just as important as understanding the product it sells.

Intellectual Property

Perhaps the single most valuable asset within many biotechnology companies is not their laboratories.

It is their intellectual property.

Patents.

Manufacturing processes.

Scientific know-how.

Licensing agreements.

Commercial rights.

One of the central questions that now emerges from this investigation is remarkably simple.

Who owns the intellectual property?

Is it owned by the Foundation?

A separate holding company?

A licensing entity?

A research company?

At present, those relationships are not fully explained within the publicly available material.

Until they are, understanding where value ultimately sits within the organisation remains difficult.

Patients and Investors

Patients and investors often approach the same organisation with very different expectations.

Patients want reassurance that the treatment is safe and effective.

Investors want reassurance that the business is sustainable and capable of growth.

Both groups rely on trust.

Trust is strengthened by transparency.

The more clearly an organisation explains its structure, ownership and governance, the easier it becomes for others to make informed decisions.

That principle applies whether the organisation is a biotechnology start-up, a pharmaceutical company or a healthcare provider.

The Questions That Remain

At this stage of the investigation, several important questions remain unanswered.

• Which legal entity owns the core intellectual property?

• Which entity receives patient income?

• Which entity issued the investment announced in 2026?

• How are the various companies connected?

• What governance arrangements exist between them?

• How does the Bermuda entity interact with operations in other countries?

These are not accusations.

They are the next stage of responsible due diligence.

Conclusion

This investigation began with a scientific paper.

It has now expanded into a study of corporate structure, governance and investment.

The further I have looked, the clearer one thing has become.

Understanding a modern biotechnology company requires more than reading scientific journals.

It requires understanding how the organisation itself has been built.

Because behind every treatment is a business.

Behind every business is a structure.

And behind every structure is a story.

In the next chapter, the investigation turns to perhaps the most important unanswered question of all.

Who really owns Wellbeing International Foundation?

To answer that, we begin tracing the companies, directors, ownership records and corporate filings that sit behind the public-facing organisation.